NCT03734718View on ClinicalTrials.gov

The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

December 31, 2019

Conditions

Diabetes Mellitus, Type 1Hypoglycemia

Interventions

DRUG

GIP

Infusion of Glucose-dependent insulinotropic peptide

Trial Locations (1)

2800

Steno Diabetes Center CopenhagenSteno Diabetes Center Copenhagen, Clinical Metabolic Physiology, Hellerup

All Listed Sponsors

lead

Steno Diabetes Center Copenhagen

OTHER

NCT03734718 - The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes | Biotech Hunter | Biotech Hunter